William Annett is an experienced life sciences executive whose career has consisted primarily of senior roles in rapid growth situations. He has key strengths in entrepreneurial management, finance, and operational transformations.
For the last eight years Mr. Annett has served in a number of high profile positions at Genentech, including heading the Commercial Strategy and Project Finance groups. In the latter role he was responsible for the $1 billion Development budget and supported the entire Genentech clinical pipeline. Most recently he led one of the largest change initiatives in Genentech’s history, a $150 million/450 person program that replaced Commercial’s IT infrastructure and business processes. Following the Roche acquisition he was the Commercial lead in integrating Roche’s brands with Genentech’s processes and IT platforms .
Prior to Genentech Mr. Annett developed four early stage companies, three times as Chief Executive. This included founding a company, taking it public on NASDAQ and leading it as CEO for six years. He also led the west coast biotech practice at a large consulting company, and was a member of the senior management team at a UK private equity backed buyout that returned 100 times its investment in three years.
Mr. Annett has served on the Boards of Directors of nine profit and non-profit organizations. He received his MBA from the Harvard Business School and an MA in Psychology from John F. Kennedy University.